
Survival Outcomes of Adjuvant Chemotherapy Combined With Radiation Versus Chemotherapy Alone After Pancreatectomy for Distal Pancreatic Adenocarcinoma
Author(s) -
Bhavina Batukbhai,
Joseph M. Herman,
Marianna Zahurak,
Daniel A. Laheru,
Dung T. Le,
Christopher L. Wolfgang,
Zheng Li,
Ana De Jesus-Acosta
Publication year - 2021
Publication title -
pancreas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.061
H-Index - 104
eISSN - 1536-4828
pISSN - 0885-3177
DOI - 10.1097/mpa.0000000000001724
Subject(s) - medicine , chemotherapy , pancreatectomy , proportional hazards model , retrospective cohort study , pancreatic cancer , adenocarcinoma , stage (stratigraphy) , oncology , gastroenterology , multivariate analysis , surgery , cancer , pancreas , paleontology , biology
We evaluated survival outcomes in patients with distal pancreatic ductal adenocarcinoma (D-PDAC) after distal pancreatectomy (DP) and adjuvant chemotherapy or chemoradiation.